This master's program aims to equip students with in-depth knowledge of the molecular mechanisms driving various cancers and their relevance to clinical treatments. Leveraging Liverpool's status as a center of excellence in cancer care and its strong ties with institutions like the Clatterbridge Cancer Centre, the program offers a "bench to bedside" approach, integrating scientific research with clinical practice.
Curriculum: The curriculum encompasses a wide spectrum of research activities, from identifying novel targets to validating them in pre-clinical tumor models and early-phase clinical trials. Students engage with advanced techniques such as modern biotechnology, bioimaging tools, and computational biology to address critical biological questions. The program also emphasizes statistical techniques essential for designing experiments in biological research.
Research Focus: Students have the opportunity to join cancer research teams, engaging in projects that utilize cutting-edge technologies. The program's research activities span from novel target identification to their validation in clinical trials, ensuring a comprehensive research experience.
Industry Engagement: The University maintains strong collaborations with leading cancer care institutions, including the Clatterbridge Cancer Centre. These partnerships provide students with practical insights and exposure to the latest challenges in cancer research, enhancing their readiness for roles in academia, clinical trial units, and the pharmaceutical industry.
Global Perspective: The program attracts a diverse cohort, fostering a global outlook on cancer care challenges. Students benefit from the University's international collaborations and research initiatives, preparing them to implement innovative cancer therapies worldwide.